Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

BACKGROUND: To ensure the highest quality of human papillomavirus (HPV) testing in primary cervical cancer screening, novel HPV assays must be evaluated in accordance with the international guidelines. Furthermore, HPV assay with genotyping capabilities are becoming increasingly important in triage...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Ejegod, Ditte Møller, Lagheden, Camilla, Bhatia, Ramya, Pedersen, Helle, Boada, Elia Alcañiz, Sundström, Karin, Cortés, Javier, Josë, F. Xavier Bosch, Cuschieri, Kate, Dillner, Joakim, Bonde, Jesper
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7203972/
https://ncbi.nlm.nih.gov/pubmed/32375689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06888-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia